Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Beneficial effects of UV radiation other than via vitamin D production.
Anti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study.
A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.
Novel replication-competent circular DNA molecules from healthy cattle serum and milk and multiple sclerosis-affected human brain tissue.
Conventional and Advanced Imaging in Neuromyelitis Optica.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by cirrus and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
Estimating the ratio of CD4+ to CD8+ T cells using high-throughput sequence data.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Cognitive impairment among different clinical courses of multiple sclerosis.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Early and Degressive Putamen Atrophy in Multiple Sclerosis.
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative Disorders.
Associations between Klinefelter's syndrome and autoimmune diseases: English national record linkage studies.
Clinical correlations of motor and somatosensory evoked potentials in neuromyelitis optica.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
Brain Plasticity Effects of Neuromodulation Against Multiple Sclerosis Fatigue.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
Pages
« first
‹ previous
…
323
324
325
326
327
328
329
330
331
…
next ›
last »